Aug 2026· Journal of Robotic Surgery· Vol 20· 0 citations· 41 references
Medicine
TL;DR
Current evidence suggests that SPRNSM is a feasible and safe procedure with potential cosmetic and functional advantages, however, the evidence base is limited by predominantly retrospective designs, small sample sizes, selection bias toward high-volume centers, and short follow-up, preventing definitive conclusions regarding long-term oncologic safety.
Current evidence suggests that SP-RARP is a safe and feasible alternative to MP-RARP, offering improved recovery and cosmetic outcomes without compromising oncological or functional results, however, the certainty of evidence remains limited by methodological weaknesses and predominantly retrospective data.
Lalit Kumar, A. Pal, Yuhong Yuan et al.· Journal of Robotic Surgery· 0 citations
Early institutional experience suggests SP-RAKT is technically feasible in carefully selected patients at experienced centers, with minimal blood loss, short hospitalization, and early graft function consistent with established benchmarks, which support feasibility but not comparative safety or superiority over open or...
Pierangelo Nitzkowski, Aaron Ouyang, Thriaksh Rajan et al.· International Urology and Ne...· 0 citations
The available evidence suggests that reduced-port robotic surgery represents a viable option for selected patients with endometrial cancer, with broadly similar short-term perioperative outcomes to conventional multiport surgery.
Ze He, Jing-Qiong Zhan, Wen-Fan Tang· Journal of Robotic Surgery· 0 citations
Comparative evidence rests on one clinically selected, non-randomized cohort in which no difference was statistically detectable; this establishes neither equivalence nor absence of harm.
B. Mohammed, Aqsa Muskaan, Y. P. Q. Syed et al.· Journal of Robotic Surgery· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.